E. Mann Living Trust Incume... Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

E Incume EYES stock SEC Form 4 insiders trading

E has made over 1 trades of the Vivani Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently E sold 7,485,156 units of EYES stock worth $7,934,265 on 27 February 2017.

The largest trade E's ever made was selling 7,485,156 units of Vivani Medical Inc stock on 27 February 2017 worth over $7,934,265. On average, E trades about 7,485,156 units every 0 days since 2017.

You can see the complete history of E Incume stock trades at the bottom of the page.

What's E Incume's mailing address?

E's mailing address filed with the SEC is 12744 SAN FERNANDO ROAD12744 SAN FERNANDO ROAD, , SYLMARSYLMAR, CACA, 9134291342.

Insiders trading at Vivani Medical Inc

Over the last 10 years, insiders at Vivani Medical Inc have traded over $9,497,123 worth of Vivani Medical Inc stock and bought 22,269,890 units worth $31,710,900 . The most active insiders traders include Alfred E Mann, Gregg Williams e E. Mann Living Trust Incume.... On average, Vivani Medical Inc executives and independent directors trade stock every 31 days with the average trade being worth of $1,432,564. The most recent stock trade was executed by Gregg Williams on 13 June 2022, trading 3,800 units of EYES stock currently worth $7,600.

What does Vivani Medical Inc do?

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.

Complete history of E Incume stock trades at Vivani Medical Inc

Vivani Medical Inc executives and stock owners

Vivani Medical Inc executives and other stock owners filed with the SEC include:

• Jonathan McGuire,
  Director
• Stephen Okland,
  Chief Commercial Officer
• Stephen D. Okland Jr.,
  Chief Strategy & Bus. Devel. Officer
• Edward Randolph,
  Vice President - Manufacturing
• Scott Dunbar,
  Acting Chief Exec. Officer
• Dr. Jessy Dana Dorn Ph.D.,
  VP of Clinical & Scientific Affairs
• Edward David Randolph,
  VP of Operations
• Edward Jonathon Sedo,
  Acting Chief Accounting Officer & Principal Financial Officer
• Aaron Mendelsohn,
  Independent Director
• Ted Randolph,
  Vice President - Operations
• Matthew Pfeffer,
  Acting Chief Executive Officer, Director
• Gregg Williams,
  Chairman of the Board
• Lisa M. Wilson,
  Founder & Pres of In-Site Communications and Investor Relations for Second Sight
• Gunnar Bjorg,
  Founder
• Thomas B Miller,
  Chief Financial Officer
• E. Mann Living Trust Incume...,
  
• Gregoire Cosendai,
  VP of European Operations
• William J Phd Link,
  Director
• David Murray Jacques,
  VP-Research Development
• John T Blake,
  Chief Financial Officer
• William Patrick Ryan,
  Chief Operating Officer
• Jessy Dana Dorn,
  VP-Clin & Scientific Affairs
• John Anthony Moses,
  Commercial VP Americas
• Robert J. Greenberg,
  Chief Executive Officer
• Alfred E Mann,
  Director
• Anne Marie Juliette Ripley,
  VP Regulatory Affairs